Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis.
Andersen BK, Ding D, Mogensen LJH, Tu S, Holm NR, Westra J, Wijns W.
Eur Heart J Qual Care Clin Outcomes. 2023 Feb 28;9(2):99-108. doi: 10.1093/ehjqcco/qcac053.
Assessing Post-Percutaneous Coronary Intervention Physiology: Is Hyperemia Necessary?
Jeremias A, Stone GW.
JACC Cardiovasc Interv. 2020 Aug 24;13(16):1934-1936. doi: 10.1016/j.jcin.2020.06.020.
Achieving post-percutaneous coronary intervention low-density lipoprotein-cholesterol goals: Science versus reality.
Tokgozoglu L, Kocyigit D.
Eur J Prev Cardiol. 2021 Jul 23;28(8):852-853. doi: 10.1177/2047487320919867.
Optimization of Percutaneous Coronary Intervention: Is There a Place for Physiology?
Räber L, Biccirè FG.
JACC Cardiovasc Interv. 2023 Oct 9;16(19):2409-2411. doi: 10.1016/j.jcin.2023.09.002.
Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.
Park DW, Park SJ.
Circ Cardiovasc Interv. 2017 Jun;10(6):e004792. doi: 10.1161/CIRCINTERVENTIONS.117.004792.
Predictors of target lesion failure after percutaneous coronary intervention with a drug-coated balloon for de novo lesions.
Lee T, Ashikaga T, Nozato T, Nagata Y, Kaneko M, Miyazaki R, Misawa T, Taomoto Y, Okata S, Nagase M, Horie T, Terui M, Kachi D, Odanaka Y, Matsuda K, Naito M, Koido A, Yonetsu T, Sasano T.
EuroIntervention. 2024 Jul 1;20(13):e818-e825. doi: 10.4244/EIJ-D-23-01006.
Is Post-Percutaneous Coronary Intervention Fractional Flow Reserve of Value in Chronic Total Occlusions?
Tremmel JA, Fearon WF.
Circ Cardiovasc Interv. 2018 Nov;11(11):e007360. doi: 10.1161/CIRCINTERVENTIONS.118.007360.
Radial Artery Access Complications: Prevention, Diagnosis and Management.
Roy S, Kabach M, Patel DB, Guzman LA, Jovin IS.
Cardiovasc Revasc Med. 2022 Jul;40:163-171. doi: 10.1016/j.carrev.2021.12.007. Epub 2021 Dec 16.
Fibrinogen-albumin ratio predicting major adverse cardiovascular outcomes post-percutaneous coronary intervention: A systematic review and exploratory meta-analysis.
Desai R, Fadah K, Srikanth S, Neha NFN, Jain A.
Clin Cardiol. 2023 Apr;46(4):455-458. doi: 10.1002/clc.23981. Epub 2023 Feb 1.
Should Beta-Blockers Continue to Be Used in Post-Percutaneous Coronary Intervention Patients Without Myocardial Infarction?
Nappi AG, Boden WE.
JACC Cardiovasc Interv. 2016 Aug 22;9(16):1649-51. doi: 10.1016/j.jcin.2016.07.001.
